![Robert Goeltz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Goeltz
Financieel Directeur/CFO bij
ARCUS BIOSCIENCES, INC.
Vermogen: 2 M $ op 31-08-2026
Profiel
Robert C.
Goeltz is currently Chief Financial Officer at Arcus Biosciences, Inc. since 2023.
Formerly, Mr. Goeltz was Finance Director at Tularik, Inc. from 2002 to 2004, Chief Financial Officer at Onyx Pharmaceuticals, Inc. from 2013 to 2015, Chief Financial Officer & Senior Vice President at CytomX Therapeutics, Inc. from 2015 to 2017, and Chief Financial Officer at Unity Biotechnology, Inc. from 2017 to 2020.
Education includes undergraduate studies at Goizueta Business School-Emory and an MBA from UCLA Anderson School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-05-2026 | 84.161 ( 0,07% ) | 2 M $ | 31-08-2026 |
Actieve functies van Robert Goeltz
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Financieel Directeur/CFO | 01-08-2020 |
Eerdere bekende functies van Robert Goeltz
| Bedrijven | Functie | Einde |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Financieel Directeur/CFO | 01-08-2020 |
| CYTOMX THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-05-2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Financieel Directeur/CFO | 01-05-2015 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Financieel Directeur/CFO | 01-08-2004 |
Opleiding van Robert Goeltz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
72
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops senolytic medicines and biotechnology therapies targeting age-related diseases & ophthalmologic conditions | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
